Leuven
Belgium
10
2014-06-05
6
2014-06-03
These are the the leading inventors for applications assigned to TIGENIX NV:
TIGENIX NV based in Leuven, BE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
METHODS AND COMPOSITIONS FOR USE IN INTRALYMPHATIC CELLULAR THERAPIES
#2 | 2011-12-08 ✅ Patent 8,740,811 granted on 2014-06-03Biopsy device
#3 | 2011-06-30ISOLATION OF PRECURSOR CELLS AND THEIR USE FOR TISSUE REPAIR
#4 | 2010-03-18MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE PRODUCTION
#5 | 2010-02-04METHODS TO MAINTAIN, IMPROVE AND RESTORE THE CARTILAGE PHENOTYPE OF CHONDROCYTES
#6 | 2009-06-25 ✅ Patent 9,089,598 granted on 2015-07-28Method of treating connective tissue defect using chondrocytes selected for phenotypic stability
#7 | 2009-05-14 ✅ Patent 7,863,045 granted on 2011-01-04Isolation of skeletal precursor cells
#8 | 2009-05-07 ✅ Patent 7,842,502 granted on 2010-11-30Use of CXCL6 chemokine for inducing precursor cells into chondrocytes
#9 | 2009-01-27 ✅ Patent 7,482,114 granted on 2009-01-27In vivo assay and molecular markers for testing the phenotypic stability of cell populations, and selected cell populations for autologous transplantation
#10 | 2006-11-02 ✅ Patent 7,485,310 granted on 2009-02-03Use of CXCL6 chemokine in the prevention or repair of cartilage defects
66975 ⎘